2341 - 2350 of 5882 Results
Title
Year
- An integrated genomic approach to dissect the genetic landscape regulating the cell-to-cell transfer of α-synuclein2021OPENTitle: An integrated genomic approach to dissect the genetic landscape regulating the cell-to-cell transfer of α-synucleinJournal Name: Cell ReportsPublisher: Elsevier BVVol: 35Issue #: 10Start Page: 109189End Page: 109189Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.celrep.2021.109189Best OA location URL: http://www.cell.com/article/S2211124721005350/pdfCitation Count: 9
-
OPENTitle: Cognitive function in men with non-motor features of Parkinson’s diseaseJournal Name: BMJ Neurology OpenPublisher: BMJVol: 3Issue #: 1Start Page: e000112End Page: e000112Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1136/bmjno-2020-000112Best OA location URL: https://neurologyopen.bmj.com/content/bmjno/3/1/e000112.full.pdfCitation Count: 6
-
OPENTitle: Dietary Patterns and Individual Parkinsonian Signs Among Biracial Population of Older AdultsJournal Name: Current Developments in NutritionPublisher: Elsevier BVVol: 5Issue #:Start Page: 1End Page: 1Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1093/cdn/nzab033_001Best OA location URL: https://academic.oup.com/cdn/article-pdf/5/Supplement_2/1/38492179/nzab033_001.pdfCitation Count: 0
- Double blind randomized controlled trial of deep brain stimulation for obsessive-compulsive disorder: Clinical trial design2021OPENTitle: Double blind randomized controlled trial of deep brain stimulation for obsessive-compulsive disorder: Clinical trial designJournal Name: Contemporary Clinical Trials CommunicationsPublisher: Elsevier BVVol: 22Issue #:Start Page: 100785End Page: 100785Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.conctc.2021.100785Best OA location URL: https://doi.org/10.1016/j.conctc.2021.100785Citation Count: 13
-
OPENTitle: Focused WorkshopsJournal Name: European Journal of NeurologyPublisher: WileyVol: 28Issue #: S1Start Page: 23End Page: 43Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/ene.14970Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/ene.14970Citation Count: 0
-
OPENTitle: Folded concave penalized learning of high-dimensional MRI data in Parkinson’s diseaseJournal Name: Journal of Neuroscience MethodsPublisher: Elsevier BVVol: 357Issue #:Start Page: 109157End Page: 109157Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.jneumeth.2021.109157Best OA location URL: http://manuscript.elsevier.com/S0165027021000923/pdf/S0165027021000923.pdfCitation Count: 1
- Safety and Tolerability of Active Immunotherapy Targeting α-Synuclein with PD03A in Patients with Early Parkinson’s Disease: A Randomized, Placebo-Controlled, Phase 1 Study2021OPENTitle: Safety and Tolerability of Active Immunotherapy Targeting α-Synuclein with PD03A in Patients with Early Parkinson’s Disease: A Randomized, Placebo-Controlled, Phase 1 StudyJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 11Issue #: 3Start Page: 1079End Page: 1089Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-212594Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd212594?id=journal-of-parkinsons-disease%2Fjpd212594Citation Count: 47
-
OPENTitle: The Records of the Human Sciences Research CouncilJournal Name: History in AfricaPublisher: Cambridge University Press (CUP)Vol: 48Issue #:Start Page: 397End Page: 411Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1017/hia.2021.15Citation Count: 1
- Comparative pharmacovigilance assessment of mortality with pimavanserin in Parkinson disease-related psychosis2021OPENTitle: Comparative pharmacovigilance assessment of mortality with pimavanserin in Parkinson disease-related psychosisJournal Name: Journal of Managed Care & Specialty PharmacyPublisher: Academy of Managed Care PharmacyVol: 27Issue #: 6Start Page: 785End Page: 790Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.18553/jmcp.2021.27.6.785Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391001Citation Count: 8
- Development and evaluation of [18F]Flotaza for Aβ plaque imaging in postmortem human Alzheimer’s disease brain2021OPENTitle: Development and evaluation of [18F]Flotaza for Aβ plaque imaging in postmortem human Alzheimer’s disease brainJournal Name: Bioorganic & Medicinal Chemistry LettersPublisher: Elsevier BVVol: 46Issue #:Start Page: 128164End Page: 128164Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.bmcl.2021.128164Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8379902Citation Count: 13